Literature DB >> 1915274

The oct3 gene, a gene for an embryonic transcription factor, is controlled by a retinoic acid repressible enhancer.

H Okazawa1, K Okamoto, F Ishino, T Ishino-Kaneko, S Takeda, Y Toyoda, M Muramatsu, H Hamada.   

Abstract

Oct3 is an embryonic octamer-binding transcription factor, whose expression is rapidly repressed by retinoic acid (RA). In this report, we have determined the transcriptional control region of the oct3 gene and studied the mechanism of the RA-mediated repression. The chromosomal oct3 gene consists of five exons. Three subdomains of the POU region and transactivating domain are located in separate exons. Transcription initiates at multiple sites in the GC-rich region lacking a typical TATA box. The upstream 2 kb region can confer the cell type-specific expression and RA-mediated repression. Analysis of the upstream region by deletion mutagenesis locates a cis element (RARE1) which functions as a stem cell-specific, yet RA-repressible, enhancer. Footprint and gel-retardation assays show that RARE1 is composed of two domains, each of which is recognized by distinct factors. Microinjection of oct3-lacZ constructs into fertilized eggs indicates that RARE1 can function in early embryos. We suggest that RARE1 is a critical cis element for oct3 gene expression in embryonic stem cells and for the RA-mediated repression.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1915274      PMCID: PMC453014          DOI: 10.1002/j.1460-2075.1991.tb07850.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  17 in total

1.  The ubiquitous octamer-binding protein Oct-1 contains a POU domain with a homeo box subdomain.

Authors:  R A Sturm; G Das; W Herr
Journal:  Genes Dev       Date:  1988-12       Impact factor: 11.361

2.  A human lymphoid-specific transcription factor that activates immunoglobulin genes is a homoeobox protein.

Authors:  C Scheidereit; J A Cromlish; T Gerster; K Kawakami; C G Balmaceda; R A Currie; R G Roeder
Journal:  Nature       Date:  1988-12-08       Impact factor: 49.962

3.  Identification of a receptor for the morphogen retinoic acid.

Authors:  V Giguere; E S Ong; P Segui; R M Evans
Journal:  Nature       Date:  1987 Dec 17-23       Impact factor: 49.962

4.  Polarizing activity and retinoid synthesis in the floor plate of the neural tube.

Authors:  M Wagner; C Thaller; T Jessell; G Eichele
Journal:  Nature       Date:  1990-06-28       Impact factor: 49.962

5.  A cloned octamer transcription factor stimulates transcription from lymphoid-specific promoters in non-B cells.

Authors:  M M Müller; S Ruppert; W Schaffner; P Matthias
Journal:  Nature       Date:  1988-12-08       Impact factor: 49.962

6.  Isolation of male embryonal carcinoma cells and their chromosome replication patterns.

Authors:  M W McBurney; B J Rogers
Journal:  Dev Biol       Date:  1982-02       Impact factor: 3.582

7.  Tandemly reiterated negative enhancer-like elements regulate transcription of a human gene for the large subunit of calcium-dependent protease.

Authors:  A Hata; S Ohno; Y Akita; K Suzuki
Journal:  J Biol Chem       Date:  1989-04-15       Impact factor: 5.157

8.  Cloning of murine alpha and beta retinoic acid receptors and a novel receptor gamma predominantly expressed in skin.

Authors:  A Zelent; A Krust; M Petkovich; P Kastner; P Chambon
Journal:  Nature       Date:  1989-06-29       Impact factor: 49.962

9.  A third human retinoic acid receptor, hRAR-gamma.

Authors:  A Krust; P Kastner; M Petkovich; A Zelent; P Chambon
Journal:  Proc Natl Acad Sci U S A       Date:  1989-07       Impact factor: 11.205

10.  Identification of a second human retinoic acid receptor.

Authors:  N Brand; M Petkovich; A Krust; P Chambon; H de Thé; A Marchio; P Tiollais; A Dejean
Journal:  Nature       Date:  1988-04-28       Impact factor: 49.962

View more
  53 in total

1.  Pre-selection of integration sites imparts repeatable transgene expression.

Authors:  H Wallace; R Ansell; J Clark; J McWhir
Journal:  Nucleic Acids Res       Date:  2000-03-15       Impact factor: 16.971

2.  Gene expression profiling of embryo-derived stem cells reveals candidate genes associated with pluripotency and lineage specificity.

Authors:  Tetsuya S Tanaka; Tilo Kunath; Wendy L Kimber; Saied A Jaradat; Carole A Stagg; Masayuki Usuda; Takashi Yokota; Hitoshi Niwa; Janet Rossant; Minoru S H Ko
Journal:  Genome Res       Date:  2002-12       Impact factor: 9.043

3.  Impaired neural differentiation potency by retinoic acid receptor-α pathway defect in induced pluripotent stem cells.

Authors:  Pei-Shan Hou; Wen-Chin Huang; Wei Chiang; Wei-Che Lin; Chung-Liang Chien
Journal:  Cell Reprogram       Date:  2014-11-03       Impact factor: 1.987

4.  Comparative epigenetic analysis of Oct4 regulatory region in RA-induced differentiated NT2 cells under adherent and non-adherent culture conditions.

Authors:  Raha Favaedi; Maryam Shahhoseini; Mohammad Reza Akhoond
Journal:  Mol Cell Biochem       Date:  2011-12-09       Impact factor: 3.396

5.  Metabolic inactivation of retinoic acid by a novel P450 differentially expressed in developing mouse embryos.

Authors:  H Fujii; T Sato; S Kaneko; O Gotoh; Y Fujii-Kuriyama; K Osawa; S Kato; H Hamada
Journal:  EMBO J       Date:  1997-07-16       Impact factor: 11.598

6.  Retinoic acid orchestrates fibroblast growth factor signalling to drive embryonic stem cell differentiation.

Authors:  Marios P Stavridis; Barry J Collins; Kate G Storey
Journal:  Development       Date:  2010-03       Impact factor: 6.868

Review 7.  Applying whole-genome studies of epigenetic regulation to study human disease.

Authors:  J D Lieb; S Beck; M L Bulyk; P Farnham; N Hattori; S Henikoff; X S Liu; K Okumura; K Shiota; T Ushijima; J M Greally
Journal:  Cytogenet Genome Res       Date:  2006       Impact factor: 1.636

8.  Novel variants of Oct-3/4 gene expressed in mouse somatic cells.

Authors:  Nobuhiko Mizuno; Mitsuko Kosaka
Journal:  J Biol Chem       Date:  2008-09-02       Impact factor: 5.157

9.  Generation of embryonic stem cells from mouse insulin I promoter-green fluorescent protein transgenic mice and characterization in a teratoma model.

Authors:  Wieslawa M Milewski; Karla A Temple; Robin L Wesselschmidt; Manami Hara
Journal:  In Vitro Cell Dev Biol Anim       Date:  2008-10-15       Impact factor: 2.416

10.  The POU homeodomain protein OCT3 as a potential transcriptional activator for fibroblast growth factor-4 (FGF-4) in human breast cancer cells.

Authors:  Peixiang Wang; Donald R Branch; Meenakshi Bali; Gilbert A Schultz; Paul E Goss; Tianru Jin
Journal:  Biochem J       Date:  2003-10-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.